Estimaciones de analistas de Wall Street para Eledon Pharmaceuticals, Inc. (ELDN): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 4.21 |
| EV / EBITDA | -2.80 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $35000 | $22000 | $11000 | $182000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$35000 | -$22000 | -$11000 | -$182000 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $25.0M | $2.0M | $6.8M | $8.1M | $6.1M | $23.7M | $27.1M | $30.3M | $52.0M | $66.3M |
| Generales y Administrativos | $13.1M | $11.1M | $7.2M | $5.9M | $10.1M | $13.1M | $12.7M | $12.7M | $18.6M | $17.0M |
| Gastos Operativos | $38.1M | $13.1M | $14.1M | $14.0M | $18.5M | $36.9M | $88.4M | $43.0M | $70.6M | $83.3M |
| Beneficio Operativo | -$38.1M | -$13.1M | -$14.1M | -$14.2M | -$18.5M | -$36.9M | -$88.4M | -$43.0M | -$70.6M | -$83.3M |
| EBITDA | -$6.9M | -$13.1M | -$14.0M | -$15.8M | -$16.0M | -$36.7M | -$39.4M | -$116.2M | -$35.4M | -$45.3M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $9.7M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$38.0M | -$13.1M | -$14.1M | -$16.0M | -$23.2M | -$36.9M | -$88.0M | -$116.5M | -$35.8M | -$45.6M |
| Impuestos | $136000 | 0 | -$5000 | 0 | -$404000 | -$2.4M | 0 | 0 | $431000 | $35000 |
| Beneficio Neto | -$38.0M | -$13.1M | -$14.1M | -$16.0M | -$22.8M | -$34.5M | -$88.0M | -$116.5M | -$36.2M | -$45.6M |
| BPA | $-398.52 | $-41.40 | $-28.11 | $-24.42 | $-17.16 | $-2.33 | $-6.16 | $-4.73 | $-0.75 | $-0.56 |
| BPA Diluido | $-398.52 | $-41.40 | $-28.11 | $-24.42 | $-17.16 | $-2.33 | $-6.16 | $-4.73 | $-0.75 | $-0.56 |
| Acciones en Circulación (Diluidas) | $4.2M | $4.7M | $9.0M | $11.8M | $15.2M | $14.8M | $14.3M | $24.6M | $48.5M | $81.8M |
Precio
| Precio | $2.67 |
| Capitalización | $206M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABEO · ACHV · ALLO · AVIR · EDIT · HUMA · PBYI
Explorar sector: Healthcare · Biotechnology
Más secciones de ELDN: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones